No difference have been observed in the number of circulating T cells between different breast cancer subtypes, but HER2-positive and triple negative breast cancers typically have higher level of lymphocytes infiltrated in the tumor than hormone receptor positive cancers (56). This evidence concerns the gene ERBB2 and breast carcinoma.